Divergent FOXA1 Mutations Drive Prostate Tumorigenesis and Therapy-Resistant Cellular Plasticity

By
Jamie Kang
-
0
170
Investigators established FOXA1 as a multifaceted oncogene, with distinct mutational classes divergently evolving to drive prostate tumorigenesis or therapy-resistant progression.
[Science]
Abstract